Dow Jones

38 686,32

1,51%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Sucampo Pharmaceuticals, Inc. (delisted) (SCMP)
Sucampo Pharmaceuticals, Inc. (delisted) (SCMP) Actualités

SCMP

Sucampo Pharmaceuticals, Inc. (delisted) (SCMP)

Sucampo Pharmaceuticals, Inc. (delisted)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:SCMP

1 2 3 4 5 6 7 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
23/02/2018	14h27	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
16/02/2018	12h02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
15/02/2018	22h49	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
15/02/2018	00h12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
13/02/2018	22h10	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
13/02/2018	21h51	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
13/02/2018	17h17	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
13/02/2018	16h59	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
13/02/2018	16h19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
13/02/2018	15h26	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
13/02/2018	15h16	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
13/02/2018	15h08	Edgar (US Regulatory)	(25-NSE)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
06/02/2018	23h53	PR Newswire (US)	Boyd Gaming Set to Join S&P MidCap 400; Ring Energy, James River Group Holdings and EVERTEC to Join S&P SmallCap 600	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
16/01/2018	22h55	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
16/01/2018	22h34	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
27/12/2017	23h31	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
26/12/2017	13h43	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
26/12/2017	12h45	PR Newswire (US)	Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
28/11/2017	12h35	PR Newswire (US)	Free Research Reports on These Healthcare Stocks -- Sanofi, DURECT, Sucampo Pharma, and Perrigo	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
27/11/2017	22h10	GlobeNewswire Inc.	Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
21/11/2017	22h10	GlobeNewswire Inc.	Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 29th Annual Piper Jaffray Healthcare Conference	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
09/11/2017	23h48	GlobeNewswire Inc.	Sucampo to Host 2017 R&D Day on November 16 in New York	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
02/11/2017	21h13	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
01/11/2017	11h37	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
01/11/2017	11h30	GlobeNewswire Inc.	Sucampo Reports Third Quarter 2017 Financial Results	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
23/10/2017	22h05	GlobeNewswire Inc.	Sucampo Announces Third Quarter 2017 Earnings Call	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
28/09/2017	23h35	GlobeNewswire Inc.	Sucampo Pharmaceuticals Announces FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with...	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
28/09/2017	02h43	GlobeNewswire Inc.	Sucampo Pharmaceuticals Announces Presentation at Deutsche Bank’s 25th Annual Leveraged Finance Conference	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
21/09/2017	14h25	GlobeNewswire Inc.	Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Partners Roundtable Series: Rare Disease & ...	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)
20/09/2017	22h15	GlobeNewswire Inc.	Sucampo Pharmaceuticals Appoints Alex Driggs as General Counsel	NASDAQ:SCMP	Sucampo Pharmaceuticals, Inc. (delisted)